Does ACE inhibition slow progression of glomerulopathy in patients with Type 2 diabetes mellitus?
Interstitial changes appear to be more sensitive to ACE inhibition than glomerulopathy. Larger patient groups and longer treatment periods are necessary in order to detect any possible impact of ACE inhibition on the glomerular changes in Type 2 diabetes mellitus.
Introduction of a simple genetic analysis based on DGGE may improve the precision of diagnosis in FH families.